In addition, targeted inhibition of KDM1A eliminate sorafenib-resistant stem-like cells in hepatocellular carcinoma through blocking the Wnt/β-catenin signaling pathway (45). This evidence concerns the gene KDM1A and hepatocellular carcinoma.